Tübingen, Germany

Katharina Rifai

This inventor holds 12 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 11 EPO patents. Top assignees: Carl Zeiss Vision International Gmbh, Tooz Technologies Gmbh, Carl Zeiss Ag. Active years: 2018-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Katharina Rifai. Retrieved from https://idiyas.com/inventor/katharina-rifai

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 

% Patents Active = 100.0


 

Average Co-Inventor Count = 3.3

ph-index = 2

Forward Citations = 8(Granted Patents)


Location History:

  • Tuebingen, DE (2018 - 2019)
  • Tübingen, DE (2019 - 2024)

Company Filing History:


Years Active: 2018-2025

Loading Chart...
Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: Inventor Katharina Rifai

Introduction: Katharina Rifai is a pioneering inventor based in Tübingen, Germany, known for her innovative contributions to various fields.

Latest Patents: Katharina Rifai holds several patents in the areas of biotechnology, renewable energy, and medical devices, showcasing her diverse range of expertise.

Career Highlights: With a background in bioengineering, Katharina Rifai has led groundbreaking research projects that have resulted in the development of cutting-edge technologies aimed at improving people's lives.

Collaborations: Throughout her career, Katharina Rifai has collaborated with leading research institutions, universities, and companies worldwide, fostering a culture of innovation and knowledge exchange.

Conclusion: Katharina Rifai's passion for innovation and her dedication to pushing the boundaries of science make her a standout figure in the world of inventors.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…